# Cardinal Health (CAH) — Analyst Forecast

CAH · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/cah/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 16 | 5 | 0 | 21 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $250.00 | $271.55 | $280.00 | 11 |

Last price $253.71 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 19, 2026 | RBC Capital | Initiated Coverage | Outperform | $276.00 |
| Aug 13, 2026 | Barclays | Maintained | Overweight | $275.00 |
| Aug 13, 2026 | JP Morgan | Maintained | Neutral | $260.00 |
| Aug 13, 2026 | TD Cowen | Maintained | Buy | $280.00 |
| Aug 12, 2026 | Baird | Maintained | Outperform | $274.00 |
| Aug 12, 2026 | Wells Fargo | Maintained | Overweight | $277.00 |
| Aug 12, 2026 | UBS | Maintained | Buy | $280.00 |
| Aug 12, 2026 | Morgan Stanley | Maintained | Overweight | $265.00 |
| Aug 12, 2026 | Mizuho | Maintained | Outperform | $250.00 |
| Aug 12, 2026 | Evercore ISI Group | Maintained | Outperform | $270.00 |
| Aug 12, 2026 | Citigroup | Maintained | Buy | $280.00 |
| Jul 24, 2026 | Citigroup | Maintained | Buy | $265.00 |
| Jul 23, 2026 | Mizuho | Maintained | Outperform | $240.00 |
| Jul 20, 2026 | UBS | Maintained | Buy | $274.00 |
| Jul 9, 2026 | TD Cowen | Maintained | Buy | $275.00 |
| Jul 2, 2026 | B of A Securities | Maintained | Buy | $260.00 |
| May 4, 2026 | JP Morgan | Maintained | Neutral | $215.00 |
| May 1, 2026 | Wells Fargo | Maintained | Overweight | $245.00 |
| May 1, 2026 | TD Cowen | Maintained | Buy | $255.00 |
| May 1, 2026 | Citigroup | Maintained | Buy | $245.00 |

## Frequently Asked Questions

### What is the price target for CAH stock?

The average 12-month analyst price target for Cardinal Health (CAH) is $271.55, with a high estimate of $280.00 and a low of $250.00, across 11 analysts.

### Is CAH a buy, sell, or hold?

Analysts covering Cardinal Health currently average a Buy rating: 16 buy, 5 hold and 0 sell, from 21 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for CAH?

The average price target of $271.55 implies 7.03% upside from the last price of $253.71.

### What is the latest analyst rating on CAH?

On Aug 19, 2026, RBC Capital initiated coverage of Cardinal Health at Outperform with a price target of $276.00.

## Similar Stocks

- [COR](https://www.lighthorse.io/tickers/cor) — Cencora, Inc. Common Stock
- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [MMSI](https://www.lighthorse.io/tickers/mmsi) — Merit Medical Systems, Inc. - Common Stock
- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [ELV](https://www.lighthorse.io/tickers/elv) — Elevance Health, Inc. Common Stock
- [ITGR](https://www.lighthorse.io/tickers/itgr) — Integer Holdings Corporation Common Stock
- [HAE](https://www.lighthorse.io/tickers/hae) — Haemonetics Corporation Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).